BOX (Oxygen)
In comatose patients following cardiac arrest does a restrictive compared with a liberal oxygenation strategy, reduce death or survival at discharge with a poor neurological outcome?
Continue reading »Year: 2022
BOX Trial: Blood Pressure
Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest Kjaergaard et al | New England Journal of Medicine| August 2022 DOI: 10.1056/NEJMoa2208687 Clinical Question In patients with return of spontaneous circulation (ROSC) after cardiac arrest does a higher MAP target (> 77mmHg) compared to a standard target (>63mmHg) reduce death or survival at discharge with a poor neurological status? Background Manipulation […]
Continue reading »Critical Care Evidence Updates – September 2022
What’s new in the Critical Care literature – monthly updates
Continue reading »Emergency Evidence Updates – September 2022
What’s new in the Critical Care literature – monthly updates
Continue reading »Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis
In adults with acute pancreatitis does aggressive fluid resuscitation compared to moderate resuscitation result in a reduction in the development of moderately severe or severe pancreatitis?
Continue reading »Critical Care Evidence Updates – August 2022
What’s new in the Critical Care literature – monthly updates
Continue reading »Emergency Evidence Updates – August 2022
What’s new in the Critical Care literature – monthly updates
Continue reading »LOVIT Trial
In adult patients with sepsis receiving vasopressor therapy, does a high dose of vitamin C in comparison to placebo, reduce the risk of death or persistent organ dysfunction at 28 days?
Continue reading »CandiSep
In septic adults at high risk for invasive candida infection (ICI) does the use (1,3)-β-D-glucan (BDG) guided antifungal strategy, compared with standard treatment, reduce 28-day mortality compared to standard care?
Continue reading »Critical Care Evidence Updates – July 2022
What’s new in the Critical Care literature – monthly updates
Continue reading »